Veracyte | VCYT - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Agenus USD -10.61M 263.52M 2025-12
Agilent USD 442M 1000K 2025-09
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD 28.27M 7.85M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Illumina USD 157M 220M 2026-03
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Laboratory Of America USD 8.73B 8.54B 2026-03
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Siemens EUR 2.39B 505M 2025-09
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 40.63M 21.74M 2025-12
Waters USD 264.18M 94.06M 2025-12